Hemagen Diagnostics, Inc.
HMGN
$0.00
$0.000.00%
| 09/30/2012 | 06/30/2012 | 03/31/2012 | 12/31/2011 | 09/30/2011 | |
|---|---|---|---|---|---|
| Revenue | 4.04M | 4.31M | 4.77M | 4.87M | 5.14M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 4.04M | 4.31M | 4.77M | 4.87M | 5.14M |
| Cost of Revenue | 2.43M | 2.63M | 2.87M | 3.01M | 3.18M |
| Gross Profit | 1.61M | 1.68M | 1.89M | 1.86M | 1.96M |
| SG&A Expenses | 2.01M | 2.22M | 2.36M | 2.49M | 2.43M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 4.48M | 4.88M | 5.26M | 5.51M | 5.61M |
| Operating Income | -437.90K | -563.70K | -491.20K | -636.00K | -472.80K |
| Income Before Tax | -907.30K | -1.03M | -942.20K | -1.07M | -876.40K |
| Income Tax Expenses | -- | 0.00 | 0.00 | 0.00 | 4.20K |
| Earnings from Continuing Operations | -0.91 | -1.03 | -0.94 | -1.06 | -0.88 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -907.30K | -1.03M | -942.20K | -1.06M | -880.50K |
| EBIT | -437.90K | -563.70K | -491.20K | -636.00K | -472.80K |
| EBITDA | -273.70K | -391.70K | -311.90K | -453.70K | -287.00K |
| EPS Basic | -0.06 | -0.07 | -0.06 | -0.07 | -0.06 |
| Normalized Basic EPS | -0.04 | -0.04 | -0.04 | -0.04 | -0.04 |
| EPS Diluted | -0.06 | -0.07 | -0.07 | -0.07 | -0.06 |
| Normalized Diluted EPS | -0.04 | -0.04 | -0.04 | -0.04 | -0.04 |
| Average Basic Shares Outstanding | 61.98M | 61.97M | 61.95M | 61.93M | 61.91M |
| Average Diluted Shares Outstanding | 61.98M | 61.97M | 61.95M | 61.93M | 61.91M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
